WASHINGTON, DC - NOVEMBER 06: U.S. President Donald Trump, joined by members of the pharmaceutical industry and administration officials, delivers remarks on lowering drug prices in the Oval Office at ...

Credit: Getty Images Direct-to-consumer telehealth companies have exploded in popularity in recent years, presenting unique challenges and opportunities for care. The Food and Drug Administration (FDA ...

We recently published 10 Hot Stocks Sparking Buying Frenzy. Hims & Hers Health Inc. (NYSE:HIMS) is one of the best performers on Tuesday. Hims & Hers rallied for a second day on Tuesday, adding 5.86 ...

Hims & Hers Health Inc. (NYSE:HIMS) stock is trading lower on Tuesday. The U.S. Food and Drug Administration (FDA) issued a warning letter to Hims & Hers Health, dated Sept. 9, addressed to the ...

While the pharmaceutical industry has reacted negatively to President Trump’s May 12 “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” Executive Order (Executive Order), ...

Regulators sent about 100 warning letters this week to drug advertisers, including to Hims & Hers, a major online provider of weight-loss drugs. By Christina Jewett Rebecca Robbins and Dani Blum The ...

Sept 10 (Reuters) - Hims & Hers Health (HIMS.N), opens new tab said on Wednesday it is launching a new category in men's health, offering access to personalized treatment plans for low testosterone.

Hims & Hers Health HIMS2.09%increase; green up pointing triangle is launching treatments for low testosterone on its telehealth platform, venturing deeper into a category often marred by stigma, ...